scholarly journals Evaluation of anal cytology and dysplasia in women with a history of lower genital tract dysplasia and malignancy

2016 ◽  
Vol 141 (3) ◽  
pp. 492-496 ◽  
Author(s):  
Beth Cronin ◽  
Amy Bregar ◽  
Christine Luis ◽  
Steven Schechter ◽  
Paul Disilvestro ◽  
...  
Sexual Health ◽  
2013 ◽  
Vol 10 (6) ◽  
pp. 587 ◽  
Author(s):  
Katina Robison ◽  
Beth Cronin ◽  
Christine Luis ◽  
Paul DiSilvestro ◽  
Melissa Clark

Objective To compare the prevalence of abnormal anal cytology and high-risk HPV among women with a recent history of HPV-related genital neoplasia to women without a history of HPV-related genital neoplasia. Methods: A cross-sectional pilot study was performed. Women with a history of high-grade cervical, vulvar, or vaginal dysplasia or cancer within the past 2 years were eligible for the exposed group. Women without a history of high-grade anogenital dysplasia or cancer were eligible for the control group. Anal cytology and HPV genotyping were performed after informed consent was obtained. Results: 127 women were enrolled in the exposed group and 45 in the control group. The control group was slightly older and less likely to be current smokers. There was no difference between groups in history of anal intercourse. Forty-four per cent of the exposed group had abnormal anal cytology compared with 21.6% of the control group (P = 0.03). High-risk HPV was detected in the anal canal of 6 in the exposed group compared with none in the control group (P = 0.2). Fourteen per cent of the anal cytology results were read as insufficient in both groups. HPV results were insufficient in 29.2% of exposed versus 43.5% of control (P = 0.2). Conclusions: Women with a history of lower genital tract dysplasia are more likely to have a positive anal cytology result compared with women without a history. Additional information is needed to determine the best method of anal cancer screening among women with a history of lower genital tract dysplasia.


2015 ◽  
Vol 126 (6) ◽  
pp. 1294-1300 ◽  
Author(s):  
Katina Robison ◽  
Beth Cronin ◽  
Amy Bregar ◽  
Christine Luis ◽  
Paul DiSilvestro ◽  
...  

2018 ◽  
Vol 5 ◽  
pp. S7
Author(s):  
K. Leber ◽  
M. van Beurden ◽  
H.J. Zijlmans ◽  
L. Dewit ◽  
O. Richel ◽  
...  

2005 ◽  
Vol 97 (24) ◽  
pp. 1816-1821 ◽  
Author(s):  
Svetlana Vinokurova ◽  
Nicolas Wentzensen ◽  
Jens Einenkel ◽  
Ruediger Klaes ◽  
Corina Ziegert ◽  
...  

2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Jing Zhang ◽  
Guangcong Liu ◽  
Xiaoli Cui ◽  
Huihui Yu ◽  
Danbo Wang

Abstract Background Multicentric intraepithelial lesions of the lower genital tract (multicentric lesions) were defined as intraepithelial lesions of two or three sites within cervix, vagina, and vulva occurring synchronously or sequentially. The characteristics of multicentric lesions has been poorly understood. This study aimed to evaluate the risk factors for multicentric lesions, including specific HPV genotypes. Methods A retrospective case-control study was performed involving patients histologically diagnosed with multicentric lesions between January 2018 and October 2019. Controls were patients histologically diagnosed with single cervical intraepithelial neoplasia (CIN) and admitted during the same period. Univariable and multivariable analyses were used to assess the risk factors for multicentric lesions. Results Of 307 patients with multicentric lesions, the median age was 50 years (interquartile range: 43–55.5), and they were older than patients with single CIN (median age: 43 years, interquartile range: 36–50). In the multicentric lesion group, the proportions of cytologic abnormalities, HPV positivity, and multiple HPV infections were 68.9, 97.0, and 36.5%, respectively. In the multivariable analysis, menopause, a history of malignant tumors beyond the lower genital tract and multiple HPV infections were associated with the incidence of multicentric lesions (Odd ratio (OR) = 3.14, 95% confidence interval (CI) 2.24–4.41; OR = 9.58, 95% CI 1.02–89.84; OR = 1.47, 95% CI 1.03–2.10). The common HPV genotypes were HPV16, HPV53, HPV58, HPV52, HPV51, HPV56 and HPV18 in patients with multicentric lesions. The proportion of HPV16 infection was higher in high-grade lesions group than that in low-grade lesions group (OR = 2.54, 95% CI 1.34–4.83). The OR for multicentric lesions, adjusted for menopause, smoking, gravidity, parity, a history of malignant tumor beyond the lower genital tract and multiple HPV infection, was 1.97 (95% CI 1.04–3.75) in patients with HPV51 infection. Conclusions Multicentric lesions were associated with menopause, a history of malignant tumors and multiple HPV infections. HPV16 was the most common genotype, especially in high grade multicentric lesions and HPV51 infection was found to be a risk factor for detecting multicentric lesions.


2013 ◽  
Vol 42 (5) ◽  
pp. 396-400 ◽  
Author(s):  
L. H. Cardinal ◽  
P. Carballo ◽  
M. C. Cabral Lorenzo ◽  
A. García ◽  
V. Suzuki ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document